Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Preventive Treatment With Sulfadoxine/Pyrimethamine During Pregnancy Among HIV-Positive and HIV-Negative Women: 2-Dose Versus Monthly - Malawi

NCT00126906 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.

NCT NCT00126906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Preventive Treatment With Sulfadoxine/Pyrimethamine During Pregnancy Among HIV-Positive and HIV-Negative Women: 2-Dose Versus Monthly - Malawi
Lead sponsor
Centers for Disease Control and Prevention
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2002
Completion date
March 31, 2005
Enrollment
700
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, malaria, falciparum